Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Margin

    Back to All Ratios
LASA SUPERGENERICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 2.13-5.0911.6823.3317.91

What is the latest Core EBITDA Margin ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Margin ratio of LASA SUPERGENERICS is 2.13 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20242.13
Mar2023-5.09
Mar202211.68
Mar202123.33
Mar202017.91

How is Core EBITDA Margin of LASA SUPERGENERICS Trending?

Years Core EBITDA Margin % Change
Mar2024 2.13
Positive
Mar2023 -5.09
Negative
Mar2022 11.68
-49.94
Mar2021 23.33
30.26
Mar2020 17.91 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Margin ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹59.0 Cr -7.6% 7.2% -50.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,667.0 Cr 1.8% 3.4% 7.3% Stock Analytics
DIVIS LABORATORIES ₹180,131.0 Cr -0.7% 3.8% 49.3% Stock Analytics
CIPLA ₹119,745.0 Cr -0.2% -1.1% -2.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,603.0 Cr 5.8% 8.6% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,429.0 Cr 0.7% -3.8% -7.3% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-7.6%

7.2%

-50.5%

SENSEX

-1.1%

0.8%

2.2%


You may also like the below Video Courses